Skip to main content

Royce & Associates LP

SEC CIK
0000906304
Latest filing
Aug 14, 2026

FATE holding history

Fate Therapeutics Inc in every 13F filed by Royce & Associates LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

FATE overviewAll 13F holders of FATEFull Q2 2026 holdings

Shares (Q2 2024)
0
Sold out in Q2 2024
Value
$0
% of portfolio
0.0%
Quarters held
3
Since Q3 2023
Holdings of FATE by Royce & Associates LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20240$00.0%−43,399−100.0%Sold outHolders
Q1 202443,399$318.5K<0.1%−63,919−59.6%ReducedHolders
Q4 2023107,318$401.4K<0.1%+76,979+253.7%AddedHolders
Q3 202330,339$64.3K<0.1%+30,339NewHolders